| Followers | 145 |
| Posts | 27600 |
| Boards Moderated | 3 |
| Alias Born | 02/07/2004 |
Tuesday, October 03, 2023 4:29:52 AM
Ms. Jenkins will share commercial launch updates for Omisirge™ (omidubicel-onlv), the company's allogeneic stem cell therapy, and an overview of the market opportunity.
Hopefully data of substance!
Bullish
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
